期刊文献+

甲磺酸多沙唑嗪合成工艺研究 被引量:1

Study on Synthesis of Doxazosin Mesylate
下载PDF
导出
摘要 以邻苯二酚与环氧氯丙烷为原料,经环合、氧化、氯化、酰化、缩合、成盐等反应合成了治疗高血压和良性前列腺增生的药物甲磺酸多沙唑嗪。原料廉价,易得,反应条件温和,操作方便。 Doxazosin mcsylate used in the therapy of hypertension and benign prostatic hyperplasia was synthesized from catechol by cyclization, oxidation, chlorination, aminatio and condensation to give doxazosin followed by salt formation with methane sulfonic acid with an overall yield of 19.4 %. The reaction conditions are mild and the raw materials are commercially available.
出处 《广东化工》 CAS 2011年第7期50-50,60,共2页 Guangdong Chemical Industry
关键词 甲磺酸多沙唑嗪 邻苯二酚 合成 doxazosin mesylate catechoh synthesis
  • 相关文献

参考文献8

  • 1黄东平,王仁顺.多沙唑嗪治疗下泌尿系症状和前列腺增生的现状与进展[J].医学临床研究,2005,22(3):389-392. 被引量:6
  • 2陈静,谌英武.甲磺酸多沙唑嗪合成路线图解[J].中国医药工业杂志,2000,31(2):95-96. 被引量:2
  • 3Simon F C, Michael J D, Hardstone J D. et al. 2,4-Diamino-6,7- dimethoxyquinazolines. 1,2-[4-(1,4-benzodioxan-2-yl-carbonyl) piperazin-l-yl] derivatives as alpha.adrenoceptor antagonists and antihypertensive agents[J]. JMedChem, 1987, 30(1): 49-57.
  • 4王功霞,孙清,孙玲,崔新强,黄庆云.甲磺酸多沙唑嗪合成工艺研究[J].齐鲁药事,2006,25(1):45-47. 被引量:6
  • 5John K, Souren A, Gustav J M. Derivatives of 1,4-benzodioxan-2-car boxamides[J]. J Am Chem Soc, 1955, 77(20): 5373-5375.
  • 6Althuis T-H, Hess H J. Synthesis and identification of the major metabolites of Drazosin formed in dog and rat[J]. J Med Chem, 1977, 20(1): 146-149.
  • 7罗家谦,马兴田罗.甲磺酸多沙唑嗪合成工艺:中国.99117037[P].2002-04-24.
  • 8Campbell S F. Antihypertensive 4-amino-2-[4-(l,4-benzodioxan-2-carbonyl) piperazin-l-yl or homopiperazin- 1 -yl]quinazolines : US : 19804188390[P]. 1980-02-12.

二级参考文献22

  • 1Kirby RS, Andersen M, Gratzke P, et al. A combined analysis of double-blind trial of the efficacy and tolerability of doxazocin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with BPH[J].BJU Int,2001, 87:192-200.
  • 2Kirby RS. A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with BPH[J].BJU Int, 2003, 91:41-44.
  • 3Kypranou N, Lituak JP, Borkowski A, et al. Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia[J].J Urol,1998, 159:1810-1815.
  • 4Chon JK. Alphal-adrenoceptor antagonists doxazosin and terazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostate hyperplasia[J].J Urol,1999, 161: 2002-2008.
  • 5Cal C, Uslu R, Gunaydim G, et al. Doxazosin: a new cytotoxic agent for prostate cancer[J].Br J Urol, 2000, 85:672-675.
  • 6Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension study: Final results[J].JAMA,1993, 270: 8-12.
  • 7ALLHAT Collaborative Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The antihypertensive and lipid-lowering treatment to prevent heart attack trial[J].JAMA,2000, 283: 1967-1975.
  • 8Cho YH, Kim DG, Lee KS, Effects of doxazosin on sexual function in patients with benign prostatic hyperplasia[J].The Korean J Urol,2004 45(2): 130-134.
  • 9Chapple CR. The total approach in low urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) management: introduction and conclusion[J].Eur Urol,2003, 2: 1.
  • 10Lepor H. For the terazosin research group: Long-term efficacy and safety of terazosin in patients with BPH[J].Urology, 1995, 45: 406-409.

共引文献8

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部